Concord Medical Services Hldg Ltd (NYSE:CCM) has been given an average broker rating score of 3.70 (Sell) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a sell rating.
Brokerages have set a 12 month consensus price objective of $3.00 for the company and are forecasting that the company will post $0.02 EPS for the current quarter, according to Zacks. Zacks has also given Concord Medical Services an industry rank of 225 out of 265 based on the ratings given to related companies.
Several research analysts have recently issued reports on CCM shares. Zacks Investment Research upgraded shares of Concord Medical Services from a “hold” rating to a “buy” rating and set a $3.25 target price on the stock in a research note on Monday, April 2nd. ValuEngine cut shares of Concord Medical Services from a “hold” rating to a “sell” rating in a report on Monday, April 2nd.
CCM traded up $0.20 during mid-day trading on Friday, reaching $3.02. The stock had a trading volume of 7,710 shares, compared to its average volume of 7,576. The firm has a market capitalization of $130.96, a price-to-earnings ratio of -3.47 and a beta of 0.73. Concord Medical Services has a 52 week low of $2.46 and a 52 week high of $4.74.
COPYRIGHT VIOLATION WARNING: “Zacks: Concord Medical Services Hldg Ltd (CCM) Given $3.00 Consensus Price Target by Brokerages” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/08/zacks-concord-medical-services-hldg-ltd-ccm-given-3-00-consensus-price-target-by-brokerages.html.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
Get a free copy of the Zacks research report on Concord Medical Services (CCM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.